You are here

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Long term impact of screening for type 2 diabetes mellitus – a commentary on new evidence
  1. Helen C Eborall
  1. Department of Health Sciences, University of Leicester, Leicester, UK
  1. Correspondence to : Dr Helen C Eborall, Department of Health Sciences, University of Leicester, 22-28 Princess Road West, Leicester LE1 6TP, UK; hce3{at}le.ac.uk

https://doi.org/10.1136/ebmed-2015-110208

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Echouffo-Tcheugui JB, Simmons RK, Prevost AT, et al. Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior. Ann Fam Med 2015;13:149–57.OpenUrlAbstract/FREE Full Text

    Context

    Despite fulfilling many of the criteria for a screening programme, population-based screening for type 2 diabetes mellitus (T2DM) continues to be the focus of debate, chiefly concerning the balance of benefits against harms.1–3 This paper contributes by analysing the long-term impact of a single round of population-based screening on three key outcomes: (1) cardiovascular morbidity—which modelling data suggests could be reduced by screening; (2) self-rated health—an independent predictor of morbidity and mortality and (3) health-related behaviour—particularly the potential for continued engagement in ‘unhealthy’ behaviours from false reassurance following a negative screening test. This paper addresses the …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.